These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 14602869

  • 21. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA, Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ.
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [Abstract] [Full Text] [Related]

  • 22. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V, Pirotte B, Gérard C, Dargent JL, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T.
    Hum Gene Ther; 1996 Mar 20; 7(5):627-35. PubMed ID: 8845388
    [Abstract] [Full Text] [Related]

  • 23. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.
    Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G.
    J Nucl Med; 1997 Feb 20; 38(2):287-94. PubMed ID: 9025757
    [Abstract] [Full Text] [Related]

  • 24. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T.
    Cancer Gene Ther; 1997 Feb 20; 4(2):91-6. PubMed ID: 9080117
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 20; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 26. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S.
    Cancer Gene Ther; 2000 Jun 20; 7(6):947-53. PubMed ID: 10880027
    [Abstract] [Full Text] [Related]

  • 27. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
    Eastham JA, Chen SH, Sehgal I, Yang G, Timme TL, Hall SJ, Woo SL, Thompson TC.
    Hum Gene Ther; 1996 Mar 01; 7(4):515-23. PubMed ID: 8800746
    [Abstract] [Full Text] [Related]

  • 28. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.
    Engelmann C, Panis Y, Bolard J, Diquet B, Fabre M, Nagy H, Soubrane O, Houssin D, Klatzmann D.
    Hum Gene Ther; 1999 Jun 10; 10(9):1545-51. PubMed ID: 10395379
    [Abstract] [Full Text] [Related]

  • 29. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D, Hardin J, Ray J, Gage FH.
    J Neurosurg; 1993 Nov 10; 79(5):729-35. PubMed ID: 8410252
    [Abstract] [Full Text] [Related]

  • 30. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O, Blaese RM, Morris JC.
    Hum Gene Ther; 1999 Nov 01; 10(16):2679-87. PubMed ID: 10566896
    [Abstract] [Full Text] [Related]

  • 31. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg RG.
    Cancer Res; 1999 Oct 15; 59(20):5186-93. PubMed ID: 10537296
    [Abstract] [Full Text] [Related]

  • 32. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E, Nagayama Y, Mawatari F, Tanaka K, Namba H, Niwa M, Yamashita S.
    Endocrinology; 1997 Nov 15; 138(11):4577-83. PubMed ID: 9348181
    [Abstract] [Full Text] [Related]

  • 33. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1996 Oct 20; 7(16):1989-94. PubMed ID: 8930659
    [Abstract] [Full Text] [Related]

  • 34. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH.
    J Neurosurg; 1994 Aug 20; 81(2):256-60. PubMed ID: 8027810
    [Abstract] [Full Text] [Related]

  • 35. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.
    Haberkorn U, Altmann A, Kamencic H, Morr I, Traut U, Henze M, Jiang S, Metz J, Kinscherf R.
    Eur J Nucl Med; 2001 Nov 20; 28(11):1690-6. PubMed ID: 11702112
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
    Touraine RL, Vahanian N, Ramsey WJ, Blaese RM.
    Hum Gene Ther; 1998 Nov 01; 9(16):2385-91. PubMed ID: 9829537
    [Abstract] [Full Text] [Related]

  • 37. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y, Deb NJ, Garg M, Kabarriti R, Alfieri A, Takahashi M, Roy-Chowdhury J, Guha C.
    Radiat Res; 2014 Aug 01; 182(2):191-200. PubMed ID: 24972258
    [Abstract] [Full Text] [Related]

  • 38. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
    Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF.
    Hum Gene Ther; 1993 Feb 01; 4(1):39-69. PubMed ID: 8384892
    [Abstract] [Full Text] [Related]

  • 39. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Feb 01; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 40. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R, Munshi A, Abboud CN, Marrogi AJ, Freeman SM.
    Cancer Gene Ther; 1996 Feb 01; 3(6):373-84. PubMed ID: 8988840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.